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Abstract
There is strong experimental evidence of the influence of surfactants (e.g., fatty
acids) on the kinetics of amyloid-fibril formation. Yet, the structures of mixed
assemblies and interactions between surfactants and fibril-forming peptides are
still not clear. Here, coarse-grained simulations are employed to study the aggre-
gation kinetics of amyloidogenic peptides in the presence of amphiphilic lipids.
The simulations show that the lower the fibril-formation propensity of the pep-
tides the higher the influence of the surfactants on the peptides self-assembly
kinetics. In particular, the lag phase of weakly aggregating peptides increases
because of the formation of mixed oligomers, which are promoted by hydropho-
bic interactions and favorable entropy of mixing. A transient peak in the num-
ber of surfactants attached to the growing fibril is observed before reaching the
mature fibril in some of the simulations. This peak originates from transient
fibrillar defects consisting of exposed hydrophobic patches on the fibril surface,
which provide a possible explanation for the temporary maximum of fluores-
cence observed sometimes in kinetic traces of the binding of small-molecule
dyes to amyloid fibrils.
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Introduction
Amyloid-related diseases are cureless illnesses whose major hallmark is the
aggregation of peptides or misfolded proteins. Despite intense research efforts it
is still not clear if the toxic species are the insoluble fibrils or soluble oligomeric
species, or both. Soluble oligomers have been linked with disease progression
in Alzheimer’s disease [1, 2, 3], Parkinson’s disease [4, 5], type II diabetes mel-
litus [6] and other amyloid-related diseases [7]. A stable, soluble aggregate of
the Alzheimer’s Aβ1−42 peptide has been observed upon incubation in the pres-
ence of free fatty acids or sodium dodecyl sulfate (SDS) [8]. This oligomeric
form, termed globulomer, was found to induce neuropathologies by suppress-
ing the synaptic activity [9]. Globulomers seem to be formed off-pathway, i.e.,
independent of fibril-formation [10]. Structural studies involving atomic force
microscopy and nuclear magnetic resonance suggested that there are two main
species of Aβ globulomers, with N=2-6 or 12-16 peptides per aggregate [11],
but fine details on the structures of those are not available. Radiolabeled de-
tergent and size exclusion chromatography experiments indicate approximately
one SDS molecule per peptide, but the shape of globulomers and probably
also the number of bound molecules depend on surfactant concentration [8]. It
should be noted that the term globulomer is sometimes used in the literature as
an acronym for globular oligomers, irrespective to the presence of surfactants.
Here, we use this term only when we discuss oligomers that are made of peptides
and surfactants together.
Following the identification of disease-related soluble oligomers generated
through interactions between amyloidogenic (poly)peptides and fatty-acids or
other surfactants [4, 8], few structural and biophysical studies were aimed at
characterizing these interactions. SDS and several types of fatty acids induce
formation of β2-microglobulin fibrils, which may have clinical relevance for
β2-microglobulin related amyloidosis [12]. Furthermore, binding to detergent
micelles promote conformational transitions in the islet amyloid polypeptide
(IAPP) [13] and Aβ peptide [14, 15]. Soluble oligomers can also be formed from
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a mixture of equine-lysozyme and oleic acid by ion-exchange chromatography.
These oligomers are cytotoxic and interact with the thioflavin T dye, similar to
amyloid fibrils, although they are not fibrillar [16].
Only few experimental studies deal with kinetic and structural aspects of
surfactant-induced amyloid peptide oligomer formation. Computational studies
at different levels of approximation of multipeptide systems have been performed
to help the interpretation of the experimental data on amyloid aggregation [17,
18, 19, 20, 21, 22, 23, 24, 25, 26]. Yet, as of today no simulation study of the
effects of surfactants on amyloid aggregation has been reported. Here we use a
simple model of an amphipathic peptide (coarse-grained phenomenological) [27,
28] to study the aggregation of amyloid peptides in the presence of surfactant
molecules. More explicitly, the simplified peptide model can adopt two states,
amyloid-prone (β) and amyloid-protected (pi), where the free energy difference
between the two states is the only free parameter, dE = Epi - Eβ (Figure 1A). The
lower (more negative) the value of dE, the less amyloidogenic is the peptide, and
variations of dE reproduce the broad range of experimentally observed pathways
and kinetics of aggregation [27, 28] as well as fibril polymorphism [29]. Using
this very simple model enables the simulation of a system that can form soluble
oligomers as well as fibrils. Langevin simulations at 310 K are performed here
with 125 copies of the simple peptide in the presence of 0, 500, or 1000 surfactant
molecules approximated by a three-bead model [30]. The simulations indicate
that the surfactant molecules have a strong influence on the early phase of
aggregation, particularly for peptides with low amyloidogenic tendency.
Results and Discussion
In the following, the terms globulomer and mixed micelle are used for mainly
spherical (i.e., non-fibrillar) aggregates consisting of a mixture of peptides and
surfactants molecules. In contrast, the term fibril is used for aggregates whose
ordered arrangement (i.e., one-dimensional periodicity) is due solely to the self-
assembly of peptides. The peptide fibrils can host a variable number of surfac-
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tants located mainly at exposed hydrophobic surface patches.
The influence of surfactants depends on the peptide amyloidogenic tendency
The self-assembly kinetics can be analyzed by monitoring the temporal evo-
lution of the number of peptides (out of 125) in the largest cluster, i.e., largest
globulomer or fibril. In the absence of surfactants, all peptide models form
fibrils within 1 µs with a very short lag phase (Figure 2, dotted lines). At
a surfactant:peptide ratio of 8:1, the fibril formation kinetics of peptides with
dE= −1.5 kcal/mol are almost unaffected, whereas already at a ratio of 4:1
the ordered self-assembly of peptides with dE= −2.25 kcal/mol is significantly
slower mainly because of a longer lag phase (Figure 3). Moreover, for low-
amyloidogenic peptides (dE≤-2.0 kcal/mol) there is no fibrillation at all within
the simulation length of 2 µs at a surfactant:peptide ratio of 8:1, but instead the
formation of globulomers of about 40 peptides. These simulation results show
that at a 4-fold or 8-fold molar excess of surfactant the inhibition of fibrillation
depends strongly on the amyloidogenic propensity of the peptide.
It is interesting to compare the influence of surfactants on peptide aggre-
gation with the effect of inert molecules (crowders) which has been studied
recently by using the same simplified peptide model [31], a simplified analytical
model [32] and an atomistic model [33]. For peptides with low amyloidogenic
propensity, the fibril formation kinetics are slowed down in the presence of sur-
factants due to favorable surfactants/peptides interactions which result in a
longer lag phase (Figure 2). In contrast, the rate of fibril formation increases
by raising the concentration of inert crowders [31]. Apparently, the crowders
effectively reduce the volume available to the peptides, thereby enhancing their
probability to nucleate [31, 33]. Common to both surfactants and crowders ef-
fects is the strong dependence on the amyloidogenic potential of the peptide
model (i.e., dE value) and in particular the almost negligible influence in the
high amyloidogenicity regime (Figure 2 of this work and Figure 5 of [31]).
Recently, Dahse et al. have reported experimental measurements of the lag-
phase time and elongation rate constant for the aggregation of 50 µM Aβ1−40 in
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the presence of various concentrations of dihexanoylphosphatidylcholine (DHPC)
corresponding to DHPC:Aβ1−40 ratios ranging from 8:1 to 350:1 [34]. At low
DHPC concentrations (i.e., DHPC:Aβ1−40 ratios up to about 50:1) the lag phase
and elongation rate do not vary significantly by increasing the amount of DHPC.
The almost constant elongation rate is in agreement with the simulation results.
On the other hand, the strong variation of the lag phase observed in the sim-
ulations might be due to the different concentration ratios (up to 8:1 in the
simulations and 50:1 in the experiments) and/or different relative size of surfac-
tant and peptide.
The morphology of globulomers and fibrils in the presence of surfactants
The metastable and final aggregates contain a mixture of peptides and sur-
factants under all conditions used in the simulations (Table 3). The morphol-
ogy of these aggregates depends strongly on the peptide amyloidogenicity and
molar excess of surfactant (Figure 4). In the low-amyloidogenic regime (dE≤-
2.0 kcal/mol) and 8-fold molar excess of surfactants, globulomers of relatively
constant size emerge as the final product. These mixed aggregates consist of
about 40 peptides, and about four surfactant molecules per peptide (Table 3).
Both the peptides and surfactants have their hydrophobic beads oriented in-
wards and hydrophilic beads facing the bulk, as in ordinary micelles. The pep-
tides in these aggregates are predominantly in a non aggregation-prone confor-
mation, suggesting that favorable van der Waals interactions between peptides
and surfactants hinder fibril formation. Notably, micellar aggregates, made
of surfactants and peptides have been observed experimentally in mixtures of
proteins with SDS [35, 36]. At a surfactant:peptide ratio of 4:1, globulomers
are formed with a relatively small number of surfactant molecules (Figures 3,
bottom and 4, bottom). These globulomers increase significantly the length of
the lag phase. The formation of mixed assemblies is due to the similar size
of the peptide and surfactant models which are both amphipathic. In other
words, the mixing entropy of the surfactants and peptides is more favorable for
heterogeneous- than for self-assembly. It is interesting to note in this context
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that mixed clusters [37] have been observed in experiments performed with two
types of small surfactants due to the favorable entropy of mixing [38]. Calcu-
lations of entropy changes from molecular dynamics simulations are computa-
tionally and theoretically demanding, and have hitherto performed mainly on
systems such as ion and ligand binding to proteins or conformational changes in
proteins [39, 40]. Therefore, we discuss the mixing entropy only at a qualitative
level. Mixing the surfactant and peptides can yield one of three scenarios: (1)
a system of mixed micelles (2) a system with fibrils and amorphous surfactant
aggregates forming two different phases (3) fibrils coated with surfactants. The
first scenario is favored over the second owing to the entropy of mixing whereas
the third is favored by enthalpy for peptides with high amyloidogenicity.
The analysis of the structures of the fibrils grown in the presence of surfac-
tants (supplementary Figure S1) shows that the main fibrillar morphologies are
essentially identical as in previous simulations without surfactants [29]. This
observation can be explained by the location of the surfactants which are al-
most exclusively found on the surface rather than inside the fibril because of
the differences in the intermolecular interactions. The van der Waals energy be-
tween pairs of hydrophobic beads on different peptides (minimum value of -1.3
kcal/mol) is more favorable than between hydrophobic beads on peptide and
surfactant (minimum of -1.02 kcal/mol). Moreover, only the peptide-peptide
interactions have an electrostatic component, which stabilizes the fibrils when
the inner core is composed of peptides only. At 4:1 surfactant:peptide ratio,
the fibrils adsorb only few surfactant molecules. At 8-fold molar excess of sur-
factant, the largest aggregates contain both a fibrillar part consisting mainly of
peptides and amorphous aggregates of surfactants. Despite the differences in
the simulated system and details of the model, the adsorption of the surfactants
to the fibril is reminiscent of the spontaneous coating of the hydrophobic patches
of a membrane protein immersed in detergent solution observed previously in
explicit-solvent MD simulations [41].
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Transient peak of surfactants attached to the growing fibril
The time series of the number of surfactants show a transient maximum in
about half of the runs with a 4:1 surfactant:peptide ratio (Figure 5 and supple-
mentary Figures S2 and S3). In other words, a smaller number of surfactants are
attached to the mature fibril than to the growing fibril because of the transient
nature of exposed hydrophobic surface patches on the latter. This simulation
result is consistent with the peak in fluorescence of the amyloid indicator dye
thioflavin T which is sometimes present before the plateau region in measure-
ments of fibril formation kinetics (as an example, see Figure 4 of Ref. [42]). Since
the coarse-grained model is very simple and the peptide-surfactant interactions
are only van der Waals, the transient peak does not necessarily require specific
binding of the surfactants. The peak rather originates from unspecific binding
to transient defects of variable shape and size on the surface of the growing fibril
(see inset in the middle of Figure 5 as an example). In this context, it should be
noted that even monomeric β2-microglobulin can bind thioflavin T and increase
its fluorescence [43]. Thus, the simple model used in the simulations provides
a possible explanation for a counter-intuitive experimental observation. Anal-
ysis of the time series of the individual intermolecular contributions confirms
that surfactant-peptide interactions become less favorable upon fibril formation
while peptide-peptide interactions stabilize the fibrillar state (Figure 6). The
surfactant-surfactant interactions and their variation during fibril formation are
negligible and do not contribute to the stabilization of globulomers and fibrils.
Note that as mentioned above, both peptide-surfactant interactions and en-
tropic contributions favor the formation of mixed micelles which are metastable
because of the strong enthalpic stabilization of the mature fibril.
Conclusions
The comparative analysis of coarse-grained simulations of peptide aggrega-
tion in the presence and absence of surfactants suggests three main conclusions.
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First, the influence of surfactants on the peptide self-assembly kinetics depends
strongly on the fibril formation propensity of the peptides. The length of the
lag phase increases significantly for peptides with low amyloidogenic tendency
because of the formation of mixed micelles which is a consequence of the hy-
drophobic effect and entropy of mixing. Fibril nucleation takes longer from a
mixed micelle than from an oligomer consisting exclusively of peptides because
the number of peptides in the mixed micelle is smaller than the nucleus size for
fibril formation and/or the surfactants hinder the formation of a homogeneous
(i.e., peptide only) nucleus within the mixed micelle. As an example, there are
about 20 peptides in the mixed micelle at dE=-2.25 kcal/mol (Table 3) while
the nucleus for fibril formation consists of about 27 peptides [27].
Second, the structural polymorphism of the mature fibrils is essentially iden-
tical in the presence and absence of surfactants. This observation might be a
consequence of the coarse-grained model used in this study which is very simple
and lacks electrostatic interactions between peptides and lipids. Therefore, the
model better represents nonionic surfactants than lipids with several charged
groups. It cannot be excluded that specific electrostatic interactions between
peptides and ionic lipids (e.g., in zwitterionic surfactants) might shift the fibril
polymorphism towards a few privileged fibrillar structures.
Third, there is sometimes a transient peak of the number of surfactants
attached to exposed hydrophobic surface patches on the growing fibril. This
simulation result can be compared with the transitory maximum occasionally
observed in experimentally measured kinetic traces, e.g., of the amyloid indi-
cator dye thioflavin T. It is likely that the non-polar groups of thioflavin T are
mainly responsible for association to protofibrils and fibrils rather than its posi-
tively charged thiazole ring, particularly for amyloid fibrils of peptides devoid of
negatively charged side chains. Thus one possible explanation of the transient
peak is the unspecific binding dominated by surface complementarity of non-
polar groups. Moreover, the growing of isolated fibrils can be responsible of the
peak which does not necessarily require the association of two or more growing
fibrils into transient assemblies with additional binding pockets. In conclusion,
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the coarse-grained simulations indicate that very simple models can shed light
on experimental data that are difficult to interpret because important aspects
of molecular interactions and aggregation are not accessible by conventional
kinetics measurements.
Materials and methods
Coarse-grained Langevin dynamics simulations
Simplified peptides. The phenomenological coarse-grained model of an amphi-
pathic peptide is described in detail elsewhere [27, 28]. Simplified peptides con-
sists of 10 beads and have a single degree of freedom with two main states (Fig-
ure 1A). Their conformation can be either aggregation-prone (β) or aggregation-
protected (pi), where the latter conformation is 64, 39, and 15 times more pop-
ulated than the former depending on the value of dE = Epi - Eβ = −2.25, −2.0,
and −1.5 kcal/mol, respectively (see Table 4 in the supporting information of
Ref. [27]). Fibrils are stabilized by inter-peptide van der Waals interactions
and inter-peptide dipole-dipole interactions. In the absence of surfactants, from
about 80% (for dE = −2.25 kcal/mol) to about 95% (for dE = −1.5 kcal/mol)
of the peptides are part of a single fibril in the final phase, at which there is an
equilibrium between fibril and isolated peptides [27].
Coarse-grained surfactants. Surfactant molecules consist of three beads con-
nected by two bonds (Figure 1B). A hydrophilic bead represents the head group
and two hydrophobic beads represent the aliphatic tail. The surfactant model
differs from lipid models used previously in two parameters (Figure 1): the min-
imum of the van der Waals energy of the two hydrophobic beads is less favorable
and the radius of the hydrophilic bead is larger to enable the formation of amor-
phous aggregates. Using these parameters, 1000 surfactants simulated in a cubic
box of 29 nm edge form amorphous aggregates that are qualitatively similar to
those observed experimentally [44]. The average number of surfactants in the
aggregates is 2.7±0.3 at 310 K. Micelles are not the main aggregate under these
conditions, but can sporadically form. In simulations of more dilute solutions,
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i.e., 512 surfactants in a similar cubic box, micelles form the largest clusters but
most of the surfactants exist as monomers. The scaling factor of the van der
Waals interactions between peptides and surfactants is set to 1.0, i.e., scaling is
not applied, in contrast with previous studies which focused on interactions of
amyloid peptides with lipid bilayers [30, 45]. The aforementioned reduction in
the strength of the van der Waals energy of the hydrophobic beads in the lipid
model results in the spontaneous formation of mixed micelles in simulations
started from monodispersed surfactants and peptides (see the Results section).
Limitations of the simplified coarse-grained model. The coarse-grained model
that is used here to describe the peptides and the surfactants has several limi-
tations. First, it is not able to account for the specific sequence of the peptides
or describe the chemical composition of the surfactants. Rather, the physical
properties of the peptides, as related to their ability to aggregate, are included in
the dE parameter. The affinity of the surfactants to the peptides can be tuned,
as done previously with lipids [45]. This parameter was not modified here owing
to the lack of experimental reports on the interactions between different surfac-
tants and amyloid peptides. Another limitation is the lack of formal charges in
the lipids and surfactants. This is necessary to prevent artificial interactions in
the absence of explicit solvent.
Simulation protocols. The amyloid aggregation simulations are started by ran-
domly placing in a cubic box (of 29 nm edge) 125 peptide monomers (resulting
in a concentration of 8.5 mM), and 0, 500 or 1000 surfactant molecules (Ta-
ble 2), so that the distance between any pair of molecules is larger than 0.5 nm.
The system is thereafter minimized, equilibrated and simulated by Langevin
dynamics at 310 K using CHARMM [46, 47]. The bonds are constrained by
the SHAKE algorithm [48]. Apart from the number of surfactants, the only
parameter that is modified between simulations is dE, the energy difference be-
tween the amyloid-protected and amyloid-prone conformations of the peptide
in its monomeric state. Thus, the more negative the value of dE, the lower
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the amyloidogenicity, i.e., the lower the tendency of the peptides to aggregate
into fibrils. Multiple simulations are run for each value of dE and number of
surfactants, where the initial velocities are set by different random seeds. For
details on the simulations in the absence of surfactants see references [27, 28].
Analysis of the trajectories
Analysis of the simulations was carried out by routines available in Gro-
macs and home-written software, including a version of the Gromacs program
g clustsize modified by us to account for the structure and composition of the
aggregates (available upon request). The WORDOM program [49, 50] was used
to convert CHARMM trajectories to .xtc files which can be handled by Gromacs.
All figures with molecular models were produced using VMD [51].
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Tables and Figures
Rhydrophilic Rhydrophobic hydrophilic hydrophobic λ
a Reference
(nm) (nm) (kcal/mol) (kcal/mol)
0.35 0.3 -0.1 -0.8 1 this work
0.31 0.3 -0.1 -1.265 0.87-0.90 [30]
0.31 0.3 -0.1 -1.265 0.95 [45]
Table 1: Three-bead lipid and surfactant models used in coarse-grained simulations with
aggregating peptides in this and previous works. a Scaling factor for the vdW interactions
between lipids or surfactants and peptides. Different values of λ are used to model different
systems, i.e., surfactants (λ = 1), moderately attractive lipid bilayers (λ ≤ 0.9) and strongly
attractive lipid bilayers (λ ≈ 0.95).
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dE Number of Number of Number of Simulation talp k
b
e
(kcal/mol) peptides surfactants simulations time(µs) (ns) (µs−1)
-1.5 125 0 97 1.45 6.5 ± 11 11.7 ± 1.7
125 1000 20 2 0.01 8.6 ± 2.3
-2.0 125 0 99 1.45 28 ± 27 7.7 ± 1.9
125 500 20 2 78 ± 53 8.2 ± 2.4
125 1000 20 2 no fibrillation
-2.25 125 0 100 2 122 ± 135 4.8 ± 1.4
125 500 16 8 1860 ± 2150 5.8 ± 3.0
125 1000 20 2 no fibrillation
Table 2: Details of the coarse-grained simulations. The simulations without surfactants were
carried out previously [27, 30]. a Length of the lag phase. b Elongation rate. For the definition
and details on the calculation of tlp and ke see Ref. [27].
dE surfactant:peptide Largest aggregate
(kcal/mol) ratio Npeptides Nsurfactants type
-1.5 8:1 113 ± 4 120 ± 60 fibril
-2.0 8:1 38 ± 16 166 ± 7 globular aggregate
-2.25 8:1 38 ± 16 163 ± 7 globular aggregate
-2.0 4:1 105 ± 7 16 ± 6 fibril
-2.25 4:1 95 ± 9 14 ± 5 fibril
20 ± 10 16 ± 7 metastable oligomera
Table 3: Average numbers of peptides and surfactants in the largest aggregate at the end of
the simulations. aThe simulations with dE=-2.25 kcal/mol and surfactant:peptide ratio 4:1
show a mixed oligomer which dissolves within 8 µs in 15 of the 16 runs.
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Figure 1: (Caption on next page).
Figure 1: Peptide and surfactant models. (A) Simplified peptide model.
Sticks and beads representation of the monomer in the amyloid competent state
β and the amyloid protected state (pi). The large spheres are hydrophobic
(black) and hydrophilic (gray), while the two dipoles are shown with small red
and blue spheres. The interpeptide interaction energy consists of a van der
Waals term and a Coulombic term, both with a cutoff of 2 nm. The van der
Waals term has a more pronounced, i.e., more favorable, minimum energy for the
two hydrophobic spheres than the remaining eight spheres. The Coulombic term
is used for the dipole-dipole interactions. The β and pi states of the monomer
are shown on top of the two corresponding minima of the free energy plotted
as a continuous function of the dihedral angle φ of the two dipoles. Note that
the population of monomers in the β-state decreases by lowering the free energy
of the pi-state, as indicated by the green and black profiles. In the β-state, the
parallel orientation of the two intramolecular dipoles favors ordered aggregates,
with intermolecular dipolar interactions parallel to the fibrillar axis. Conversely,
the pi-state represents the ensemble of all polypeptide conformations that are not
compatible with self-assembly into a fibril. Reprinted with permission from [28].
(B) Coarse-grained model of surfactant. The length of the two bonds is 0.7 nm
and the angle between the three beads is 134◦. The beads do not bear any
partial charges. The bonds are constrained by the SHAKE algorithm [48], and
the angle is kept close to its ideal value by an harmonic potential with a force
constant of 100 kcal mol−1 degree−1. Non-bonded attraction and repulsion are
modeled by the 6-12 van der Waals energy term (parameters listed in Table 1)
with a cutoff of 2 nm.
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Figure 2: Peptide aggregation kinetics in the presence and absence of surfactants.
The number of peptides in the largest aggregate is averaged over 20 runs at each simulation
condition, i.e., for each value of aggregation propensity (dE) and each surfactant:peptide
concentration ratio. Fast aggregation without any noticeable lag phase is observed in the
absence of surfactants. At surfactant:peptide ratio of 4:1, the aggregation kinetics are slow
for peptides with low amyloidogenicity (for dE=-2.25 see the inset with the full simulation
length up to 8 µs). At surfactant:peptide ratio of 8:1, aggregation is completely inhibited for
dE = −2.0 and −2.25 kcal/mol, while highly amyloidogenic peptides (dE = −1.5 kcal/mol)
are barely affected.
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Figure 3: Fibril formation kinetics in the presence of surfactants. (Top) The number
of peptides in the largest cluster is shown as a function of simulation time for the 16 runs
with dE=-2.25 kcal/mol and surfactant:peptide ratio 4:1. Each run is shown with a different
color. The lag phase has variable length because fibril nucleation is a stochastic process. In
one of the 16 runs (red curve) fibril formation does not take place within the 8 µs simulation
length. (Bottom) Mixed oligomers are responsible for a longer lag phase in the presence of
surfactants for peptides with low amyloidogenic propensity. This representative snapshot was
taken from a simulation with dE=-2.25 kcal/mol and surfactant:peptide ratio 4:1. The lipids
are displayed with the hydrophilic head group in magenta and the two hydrophobic beads
in gray. The peptide hydrophilic and hydrophobic beads are in cyan and green, respectively,
while the dipoles are in blue and red.
Figure 4: Surfactants are part of the peptide aggregates. The time series of the average
number of surfactants attached to the largest cluster of molecules were averaged over all runs
at each condition. Representative illustrations of mixed micelles and fibrils are shown with
peptide hydrophilic and hydrophobic beads in cyan and green, respectively, peptide dipoles
in blue/red, and surfactant beads in gray.
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Figure 5: Transient peak of the number of surfactants. The number of peptides (thin
lines) and surfactants (thick lines) are shown for a simulation with dE = −2.0 kcal/mol and
a 4:1 surfactant:peptide ratio. The time series of the number of surfactants on the largest
aggregate has a peak (emphasized by vertical lines) during fibril growth before reaching the
final mature fibril. The three snapshots shown as insets represent the nucleus, fibril growth
with transient peak of surfactants, and mature fibril. Note that the surfactants (gray beads)
bind at exposed hydrophobic patches of the peptide oligomers and (proto)fibril. The protofibril
structure that represents the transient peak of surfactants shows at its bottom part a large
hydrophobic patch buried by about 10 surfactants.
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Figure 6: Interaction energies between peptides and surfactants. Time series of
the total peptide-peptide (black), peptide-surfactant (red) and surfactant-surfactant (blue)
interaction energies are shown for three representative simulations. Note that the peptide-
peptide interactions are the sum of van der Waals and Coulombic terms while the peptide-
surfactant and surfactant-surfactant interactions are only van der Waals as only the coarse-
grained peptide bears partial charges, which are located on two dipoles on each peptide (see
also caption of Figure 1). (Top) Low amyloidogenicity, i.e., dE=-2.25 kcal/mol: a simulation
where a fibril is formed. (Middle) Low amyloidogenicity, i.e., dE=-2.25 kcal/mol: a simulation
where fibril formation does not take place and the system is dominated by mixed peptide-
surfactant oligomers. (Bottom) Medium amyloidogenicity, i.e., dE=-2.0 kcal/mol. Note the
different x-axis range.
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Figure S1: Quantification of fibril morphologies. Two-dimensional frequency histograms
of the order parameter P1 and the minimum inertia moment (both described in Ref. [1])
calculated for the runs at dE=-1.5 kcal/mol and surfactant:peptide ratio 8:1 (left), dE=-
2.0 kcal/mol and 4:1 (middle), and dE=-2.25 kcal/mol and 4:1 (right). Highest frequency
is colored in yellow. The Figures can be compared with Figure S3 of [1]. Apparently, the
morphologies of the fibrils are not effected by the presence of surfactants. The lack of a peak
corresponding to a relatively rare morphology (4PF3) for the simulation at dE=-2.0 kcal/mol
is likely due to the smaller number of runs (20 simulations here and 100 in Ref. [1]).
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Figure S2: Temporal evolution of number of molecules in the largest cluster (dE=-
2.0 kcal/mol). The number of peptides (thin lines) and surfactants (thick lines) in the
largest cluster, i.e., globulomer or fibril, are shown for all simulations with dE=-2.0 kcal/mol
and 4:1 surfactant:peptide ratio.
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Figure S2 (continued)
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Figure S3: Temporal evolution of number of molecules in the largest cluster (dE=-
2.25 kcal/mol). The number of peptides (thin lines) and surfactants (thick lines) in the
largest cluster, i.e., globulomer or fibril, are shown for all simulations with dE=-2.25 kcal/mol
and 4:1 surfactant:peptide ratio. Fibril formation does not take place in one of the 16 runs
(top, middle panel), and in a few cases the fibrils do not reach their finite size after 8 µs. Note
the difference in the x-axis scale in comparison to Figure S2.
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Figure S3 (continued)
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